300+ investors in your industry, stage, and region Get
Any industry
Artificial Intelligence
Google
EdTech
Clean Energy
Retail
Enterprise Software
Local
Platforms
Travel
InsurTech
Oil and Gas
Social Impact
Cryptocurrency
SaaS
Film
Restaurants
Photography
Payments
Organic Food
Email
Fitness
CleanTech
Energy
Health Care
Machine Learning
Agriculture (AgTech)
Marketplace
Gaming
Facebook
Blockchain
B2B
Social Network
Big Data
Video Games
Education
Wellness
Medical Device
Mobile
Construction
Automotive
Legal
Sports
eSports
Hospitality
Biotechnology
Consumer
Software
Renewable Energy
Theatre
Recruiting
Crowdfunding
Web3
Medical
Fashion
Social
Venture Capital
Infrastructure
Beauty
Celebrity
Cannabis
Climate
LGBT
Publishing
Mobile Apps
Life Science
Wine and Spirits
Food and Beverage
Music
Real Estate
Art
Sporting Goods
Digital Media
Finance
Manufacturing
FinTech
Social Media
Financial Services
Franchise
Non Profit
Mobile Advertising
Internet
Android
Biotech
Proptech
Sustainability
Hardware
Transportation
Impact
Enterprise
Community
Media (Entertainment)
Any country
Burkina Faso
South Korea
Africa
LATAM
Singapore
Brazil
Saudi Arabia
Oceania
Greece
Gibraltar
Norway
Liberia
Mexico
Taiwan
Sweden
Zambia
Puerto Rico
Tunisia
Russian Federation
Togo
Tajikistan
Zimbabwe
Nigeria
Guinea
Nepal
Iran
Kyrgyzstan
Isle of Man
Pakistan
Romania
Colombia
Oman
Cameroon
New Zealand
Australia
China
Sri Lanka
Armenia
Costa Rica
Switzerland
Czech Republic
Kenya
Cayman Islands
Kuwait
Kazakhstan
Jamaica
Marshall Islands
Luxembourg
Malta
Namibia
Mozambique
Mauritius
Nicaragua
Panama
Serbia
Uganda
Turkey
Uzbekistan
Venezuela
Guatemala
Malawi
Seychelles
Moldova
Botswana
United Kingdom
Japan
South Africa
Egypt
France
Georgia
Denmark
Croatia
Hong Kong
Ghana
Iraq
Mali
Morocco
Myanmar
Latvia
Malaysia
Poland
Philippines
Portugal
Sierra Leone
Rwanda
El Salvador
Senegal
Thailand
Uruguay
Tanzania
India
Germany
Canada
Ireland
United States
Indonesia
Middle East
Bermuda
Dominican Republic
Asia
Albania
Cyprus
Qatar
United Arab Emirates
Spain
Europe
Angola
Argentina
Bangladesh
Barbados
Belgium
Ethiopia
Jordan
Austria
Azerbaijan
Ecuador
Bulgaria
Bahrain
Bahamas
Faroe Islands
Jersey
Estonia
Bolivia
Algeria
Belize
Belarus
Finland
Italy
Hungary
Israel
Grenada
Honduras
Iceland
Cambodia
Lithuania
Liechtenstein
Lebanon
Mongolia
Peru
Slovenia
San Marino
Ukraine
Vietnam
Chile
Angel Investors
VC Funds
All Investors
Download Find emails Save list
Open database

Top 50 Biotechnology VC Funds & Investors in Sweden (July 2026)

The most active venture capital funds investing in Sweden Biotechnology startups. This investor list is updated monthly from the Shizune investor database, ranked by number of investments in Sweden Biotechnology startup companies. Find investors to raise a Pre-Seed, Seed or Series A round with Shizune.
Investor Relevant Deals Geography Stage Focus Round Size
Chalmers Ventures AB
VC Fund
23 Sweden Pre-Seed, Seed Software, Biotechnology, Information Technology $5k–$2.7M
Industrifonden
VC Fund
17 Sweden, United States, Denmark Series A, Seed Biotechnology, Software, Information Technology $1.3M–$21M
Sciety
VC Fund
15 Sweden, Ukraine Seed, Series A Health Care, Biotechnology, Medical $128k–$6.3M
Almi Invest
VC Fund
15 Sweden, United States, Ukraine Seed, Pre-Seed Software, Health Care, Information Technology $193k–$2.2M
Navigare Ventures
VC Fund
8 Sweden, Denmark Seed, Series A, Venture - Series Unknown Biotechnology, Energy, Health Care $470k–$21M
HealthCap
VC Fund
5 United States, Sweden, France Series B, Series A Biotechnology, Health Care, Medical $5.7M–$92M
Novo Holdings
VC Fund
5 United States, Denmark, United Kingdom Series A, Series B, Series C Biotechnology, Health Care, Medical $9M–$135M
Voima Ventures
VC Fund
4 Finland, Sweden, Norway Seed, Pre-Seed, Series A Biotechnology, Health Care, Artificial Intelligence $439k–$30M
Karolinska
VC Fund
4 Sweden, Denmark, United States Seed, Series A Biotechnology, Health Care, Pharmaceutical $1.3M–$73M
Norrsken VC
VC Fund
4 Sweden, United Kingdom, Germany Seed, Series A Software, Artificial Intelligence, Health Care $1.1M–$56M
BackingMinds
VC Fund
3 Sweden, Denmark, Finland Seed, Pre-Seed SaaS, Energy, Software $772k–$8.2M
I Love Lund
VC Fund
3 Sweden Venture - Series Unknown, Pre-Seed, Seed Biotechnology, Medical, Software $38k–$2.2M
EIR Ventures
VC Fund
3 Denmark, Sweden, United States Series A, Seed Biotechnology, Health Care, Therapeutics $20M–$73M
Crowberry Capital
VC Fund
3 Iceland, Denmark, Finland Seed, Series A, Pre-Seed Software, Gaming, Health Care $1k–$17M
Inventure
VC Fund
3 Finland, Sweden, United States Seed, Series A, Series B Software, Information Technology, Health Care $549k–$25M
Partnerinvest Norr
VC Fund
3 Sweden, United States Seed, Series A Software, Manufacturing, Information Technology $588k–$5.3M
Nordic Science Investments
VC Fund
2 Finland, Sweden, United States Seed, Pre-Seed, Series A Biotechnology, Medical, Health Diagnostics $373k–$4.6M
Nina Capital
VC Fund
2 United States, United Kingdom, Germany Seed, Pre-Seed, Series A Health Care, Artificial Intelligence, Software $573k–$21M
SEB Venture Capital
VC Fund
2 Sweden, Denmark, United Kingdom Series A, Series B Software, Information Technology, FinTech $1.2M–$23M
Noaber
VC Fund
2 The Netherlands, Israel, Germany Seed, Series A Health Care, Medical, Fitness $1.3M–$20M
LU Holding
VC Fund
2 Sweden Seed, Pre-Seed Biotechnology, Software, Medical Device
Boehringer Ingelheim Venture Fund
VC Fund
2 United States, Germany, Switzerland Series A, Series B, Seed Biotechnology, Health Care, Therapeutics $1.8M–$50M
Life Science Invest
VC Fund
2 Sweden Seed, Pre-Seed Medical, Biotechnology, Biopharma $310k–$4.6M
Fåhraeus Startup and Growth
VC Fund
2 Sweden, Denmark, Finland Seed, Venture - Series Unknown Medical, Biotechnology, Genetics $772k–$5.6M
Hadean Ventures
VC Fund
2 Norway, Sweden, Germany Series A, Series B Biotechnology, Health Care, Medical $4.3M–$79M
ARCH Venture Partners
VC Fund
2 United States, China, United Kingdom Series A, Series B, Series C Biotechnology, Health Care, Therapeutics $8.4M–$250M
Länsförsäkringar
VC Fund
2 Sweden Seed, Pre-Seed Real Estate, Biotechnology, Manufacturing $484k–$1.1M
Faro Capital
VC Fund
2 Sweden, United States Series A, Seed Biotechnology, Gaming, Medical $2.2M–$25M
Flerie Invest
VC Fund
2 Sweden, United States, United Kingdom Series A, Series B Health Care, Biotechnology, Pharmaceutical $2.5M–$75M
Segulah Medical Acceleration
VC Fund
2 Sweden, Germany, United States Series A, Series D, Series B Health Care, Medical Device, Biotechnology $8.7M–$10M
LIU Invest
VC Fund
2 Sweden Seed, Pre-Seed Biotechnology, Information Technology, AgTech $88k–$1.4M
LifeArc Ventures
VC Fund
1 United Kingdom, United States Series A, Seed Health Care, Fitness, Wellness
Teknoinvest
VC Fund
1 Sweden, Norway, United States Series B, Series A Health Care, Biotechnology, Medical
Inven2
VC Fund
1 Sweden Series A Therapeutics, Biotechnology, Pharmaceutical
Social Starts
VC Fund
1 United States, Germany, United Kingdom Seed, Series A Software, Health Care, Artificial Intelligence
Impilo
VC Fund
1 Sweden, Denmark Biotechnology, Pharmaceutical, Medical
Monesi
VC Fund
1 Sweden Pre-Seed Life Science, Biotechnology
HJKK Didrikson
VC Fund
1 Sweden Seed Biopharma, Biotechnology, Pharmaceutical
Phase2Phase Biopharma
VC Fund
1 Sweden Seed Biopharma, Biotechnology, Pharmaceutical
Inter Ikea
VC Fund
1 Germany, Sweden, Denmark Seed, Corporate Round Software, Furniture, Health Care
Ackra Invest
VC Fund
1 Sweden Seed Manufacturing, Mining, Chemical
Unruly Capital
VC Fund
1 United Kingdom, United States, Germany Seed, Pre-Seed Biotechnology, CleanTech, Manufacturing
Leksell Social Ventures
VC Fund
1 Sweden, United States Seed, Series B Health Care, Apps, Fitness
Colibri Ventures
VC Fund
1 Sweden, Mexico Seed, Series A Gaming, Wellness, Health Care
Almi Invest GreenTech
VC Fund
1 Sweden Seed, Series A Waste Management, Energy, Manufacturing
Nxt2b
VC Fund
1 Sweden Series A Health Care, Biotechnology, Health Diagnostics
KTH Holding
VC Fund
1 Sweden Seed, Pre-Seed Software, Information Technology, Biotechnology
Nordic Foodtech VC
VC Fund
1 Finland, Sweden, Denmark Seed, Series A Biotechnology, Life Science, Water
Knutsson Holdings AB
VC Fund
1 Sweden, Germany Series C Gaming, Billing, Parking
Kale United
VC Fund
1 Sweden, United Kingdom, Canada Seed, Pre-Seed Food and Beverage, Biotechnology, Food Processing $100k–$2.5M
Access all 285 VC funds in Sweden Biotechnology startups.

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Investor list

Chalmers Ventures AB
VC Fund · Göteborg, Vastra Gotaland, Sweden · 23 investments in Sweden Biotechnology startups

We are a leading tech investor & venture builder in the Nordics. Taking deep tech from lab to market.WELCOMEINVESTMENTS

Show more...

Investment focus

  • Industry: Software, Biotechnology, Information Technology
  • Stage:Pre-Seed, Seed
  • Geography: Sweden

Investor stats

  • Total investments: 211
  • Round size: Seed $290k–$2.7M; Pre-Seed $5k–$309k
  • Lead/follow: 46% lead, 54% follow

Portfolio highlights

  • Ambidex AB — helps food retailers create new revenue streams on their refrigeration systems by stabilizing the electricity grid.
  • Anferra — Anferra specializes in hydrometallurgy, utilizing methods for resource-efficient recycling of steel industry waste into iron chloride.
  • Arkeon Technologies — Arkeon Technologies is a deep-tech company developing innovative solutions for scalable superconducting quantum computing. Its patented technology enables precise post-fabrication tuning of qubit frequencies, improving quantum chip performance, yield, and reliability. By addressing key manufacturing challenges, Arkeon helps accelerate thedevelopment of large-scale quantum processors for next-generation computing.
Show all investments...

Industrifonden
VC Fund · Stockholm, Stockholms Lan, Sweden · 17 investments in Sweden Biotechnology startups

Industrifonden is a Nordic evergreen venture capital firm with a fund size of $600m, that focuses on early-stage technology and life science companies with international potential. The company works long term with the entrepreneurs we invest in, and have a strong track record of building game changing companies. Industrifonden-backed companiesinclude tech companies Qlik, Arcam, Soundtrack Your Brand, Fishbrain, and life science companies CellaVision, Oncopeptides and AMRA.

Show more...

Investment focus

  • Industry: Biotechnology, Software, Information Technology
  • Stage:Series A, Seed
  • Geography: Sweden, United States, Denmark

Investor stats

  • Total investments: 194
  • Round size: Seed $1.3M–$6.2M; Series A $3.3M–$21M
  • Lead/follow: 40% lead, 60% follow

Portfolio highlights

  • Gesynta Pharma — Founded in 2017, Gesynta Pharma bases its R&D on research from the Karolinska Institutet. The most advanced drug candidate, GS-248, reduces inflammation and increases blood flow in the microvasculature, thereby having the potential to provide improved treatments for several serious diseases. In an ongoing clinical proof-of-concept study,GS-248 is being evaluated for its capacity to normalize vascular blood flow and reduce pain in patients with the autoimmune disease systemic sclerosis. Positive results from this study may lead to a rapid broadening of the development program towards additional indications, for example cardiovascular diseases and rheumatic diseases other than systemic sclerosis. Major shareholders include Industrifonden, Linc, Hadean Ventures, and a number of successful life science entrepreneurs. For more information, please visit www.gesynta.se
  • Peafowl Plasmonics — IOSBET menyediakan akses slot demo Pragmatic resmi dengan pilihan game terbanyak, pendaftaran mudah, sistem aman, serta pengalaman bermain nyaman tanpa risiko.
  • Trackpaw Scientific — Contributing to the development of safe and effective pharmaceuticals at increased speed and quality by digitalising the preclinical study landscape.
Show all investments...

Sciety
VC Fund · Stockholm, Stockholms Lan, Sweden · 15 investments in Sweden Biotechnology startups

Whether you are an investor or entrepreneur, partner with Sciety to achieve impactful returns and elevate your life science business in the Nordics.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Medical
  • Stage:Seed, Series A
  • Geography: Sweden, Ukraine

Investor stats

  • Total investments: 46
  • Round size: Seed $128k–$2.3M; Series A $439k–$6.3M
  • Lead/follow: 93% lead, 7% follow

Portfolio highlights

  • Encare — Encare was established in 2009 to implement the ERAS Protocols on a global basis by- providing training to health care professionals on the ERAS Protocols- providing an interactive and web-based information system for evidence based - best practice management (EBM)The company has developed an interactive, user-friendly interface forthe collection, documentation and follow-up on critical performance and quality parameters as lined out by leading clinical experts in respective protocol[1] based on, at any time, best practice and evidence.The data collected in the web-based solution is interactive and offers immediate feedback of performance, which will generate significant and sustainable improvement of efficiency and quality of care as well as generate substantial health care savings.Encare has the rights to commercialize surgical protocols developed by the ERAS Society. The company has so far rolled out the audit system to more than 120 hospitals in Canada, France, Norway, Poland, Sweden, South Africa, Switzerland, the United Kingdom, Argentina, Mexico, Colombia, Brazil, Singapore and the United States.The ERAS Society was formed in 2001 with the aim to establish evidence based protocols as best practice standards in perioperative care. ERAS Society has published a wide range of publications regarding protocols and guidelines for enhanced recovery after surgery.
  • Capitainer — Capitainer enables patients to collect their own volume-defined dried blood spot at home.Capitainer started in 2016. Their technology is a volumetric blood collection device that enables patients to conveniently and safely collect blood samples in the comfort of their own home, our technology is more accurate than today’s solutions. Capitaineroffers impressive cost and environmental savings for healthcare providers managing millions of conventional blood samples annually.
  • Single Technologies — Founded in Stockholm, Sweden, with its long tradition in fiber optics, ultra-sensitive fluorescence spectroscopy and DNA sequencing, SINGLE’s ambition is to become the instigator of 3-D Sequencing.
Show all investments...

Almi Invest
VC Fund · Stockholm, Stockholms Lan, Sweden · 15 investments in Sweden Biotechnology startups

Almi Invest is Sweden’s most active early-stage venture capital firm, investing in scalable startups across Sustainability, Industry, Tech, and Life Science.We invest from pre-seed to Series A, always co-investing with independent private investors to accelerate innovation and long-term success. Our portfolio spans sustainable solutions,industrial innovation, deep tech, SaaS, and life science, supporting startups that drive economic and environmental progress.With €430 million under management and over 1,000 investments since 2009, we have backed leading companies like MIPS, Tobii, and Neo4j, with notable exits to Google, Apple, Microsoft, and Qlik.Beyond capital, we offer engaged ownership, providing strategic guidance, active board participation, and access to an extensive investor network.Almi Invest is part of the Almi Group and is funded by the European Regional Development Fund, Almi AB, and regional partners.

Show more...

Investment focus

  • Industry: Software, Health Care, Information Technology
  • Stage:Seed, Pre-Seed
  • Geography: Sweden, United States, Ukraine

Investor stats

  • Total investments: 279
  • Round size: Seed $193k–$2.2M; Pre-Seed $236k–$1.4M
  • Lead/follow: 30% lead, 70% follow
  • Last fund: Likely still investing — fund raised in 2024

Portfolio highlights

  • Ambidex AB — helps food retailers create new revenue streams on their refrigeration systems by stabilizing the electricity grid.
  • Xaga Surgical — Xaga Surgical aims to minimize the risk of infections by inventing safer medical needles.
  • Inhalation Sciences — The PreciseInhale patented aerosol generation R&D platform delivers respirable dry powder aerosols from preclinical cell studies all the way through to human clinical trials, significantly accelerating drug development timelines. The platform’s one-animal-at-a-time system requires just milligrams, not grams of costly test substance for a fullPK study and delivers high-resolution lung data of, typically, <10% SD. We carry out Contract Research for novel and generic inhalation drug developers, toxicology and environmental research institutes and university research institutes in the inhalation and aerosolization field.
Show all investments...

Navigare Ventures
VC Fund · Stockholm, Stockholms Lan, Sweden · 8 investments in Sweden Biotechnology startups

Welcome to Navigare Ventures. We invest in transformational early-stage companies at the frontier of science and technology.

Show more...

Investment focus

  • Industry: Biotechnology, Energy, Health Care
  • Stage:Seed, Series A, Venture - Series Unknown
  • Geography: Sweden, Denmark

Investor stats

  • Total investments: 27
  • Round size: Seed $470k–$3.9M; Series A $7.3M–$21M; Venture - Series Unknown $858k–$8.5M
  • Lead/follow: 52% lead, 48% follow

Portfolio highlights

  • ProteomEdge — The objective of ProteomEdge is to use mass spectrometry to provide an analytical platform with cutting-edge precision for absolute protein quantification.
  • Arkeon Technologies — Arkeon Technologies is a deep-tech company developing innovative solutions for scalable superconducting quantum computing. Its patented technology enables precise post-fabrication tuning of qubit frequencies, improving quantum chip performance, yield, and reliability. By addressing key manufacturing challenges, Arkeon helps accelerate thedevelopment of large-scale quantum processors for next-generation computing.
  • Peafowl Plasmonics — IOSBET menyediakan akses slot demo Pragmatic resmi dengan pilihan game terbanyak, pendaftaran mudah, sistem aman, serta pengalaman bermain nyaman tanpa risiko.
Show all investments...

HealthCap
VC Fund · Stockholm, Stockholms Lan, Sweden · 5 investments in Sweden Biotechnology startups

HealthCap, a life science investor and company creator. Our motivation is to find innovative ideas and invest that could impact healthcare and society.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Series B, Series A
  • Geography: United States, Sweden, France

Investor stats

  • Total investments: 130
  • Round size: Series A $5.7M–$85M; Series B $12M–$92M
  • Lead/follow: 24% lead, 76% follow
  • Last fund: May invest from a new fund soon — raised $209M in 2019

Portfolio highlights

  • ADCendo — ADCendo ApS is a biotech company dedicated to developing new types of anti-cancer drugs. We focus on antibody-drug conjugates (ADCs) directed at novel targets, that have been found to be overexpressed by several cancer forms, that are all characterized by a significant unmet need for novel treatment.
  • Neobiomics — Neobiomics is a Swedish life-science company that develops nutritional products for preterm infants and neonatal care. Its best-known products include ProPrems® and NeoMega36®.
  • Ultragenyx Pharmaceutical — Ultragenyx is focused on developing first-ever approved treatments for rare and ultrarare diseases and moving the rare disease community forward.
Show all investments...

Novo Holdings
VC Fund · Hellerup, Hovedstaden, Denmark · 5 investments in Sweden Biotechnology startups

Novo Holdings is a world-leading life science investor with a focus on creating long-term value.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Series A, Series B, Series C
  • Geography: United States, Denmark, United Kingdom

Investor stats

  • Total investments: 351
  • Round size: Series A $9M–$125M; Series B $13M–$135M; Series C $30M–$118M
  • Lead/follow: 40% lead, 60% follow
  • Last fund: May invest from a new fund soon — raised $165M in 2018

Portfolio highlights

  • Biosyntia — Biosyntia is a biotech startup within synthetic biology and metabolic engineering. We develop biocatalysts at an unprecedented speed and efficiency by employing our patent pending high-throughput screening technology.By developing tailored processes based on biocatalysis, Biosyntia enables production of complex chemical compounds byfermentation. Biocatalysis may substantially reduce both production costs and environmental impact compared to other processes such as chemical synthesis. We partner with manufacturers of fine chemical compounds (flavors, fragrances, APIs, pigments, additives, intermediates, and more) in order to establish more sustainable manufacturing processes for a greener tomorrow.Biosyntia is located at the Novo Nordisk Foundation (NNF) Center for Biosustainability in Hørsholm, 25 kilometers north of Copenhagen.
  • IVERIC bio — IVERIC bio is a science-driven biopharmaceutical company focused on the discovery and development of novel treatment options for retinal diseases with significant unmet medical needs. The Company is currently developing both therapeutic product candidates for age-related retinal diseases and gene therapy product candidates for orphan inheritedretinal diseases.
  • Nkarta Therapeutics — Nkarta seeks to improve upon the efficacy of cell therapy, making it more potent, better tolerated and more rapidly available to a broad population of patients with a variety of hematologic and solid tumor malignancies.While T-cell therapy, often known as CAR-T, has proven successful in certain cancer indications, its promise has been limited toa few hematologic malignancies and the side effects can be severe. Natural Killer cells are the immune system’s first responders against diseases and pathogens. Unlike T cells, they have an inherent ability to target tumor cells without genetic alteration, and therefore hold significant promise in the development of potent therapies that can be used more readily for diverse tumor types. Nkarta’s differentiated cell therapy approach is designed to boost and enhance the inherent power of Natural Killer cells to target and destroy tumor cells, while also offering a better tolerated safety profile.
Show all investments...

Voima Ventures
VC Fund · Helsinki, Southern Finland, Finland · 4 investments in Sweden Biotechnology startups

Voima Ventures’ mission is to solve major global problems by combining science, entrepreneurship, and value adding capital. They shed light on the ideas and technology which require time and courage to build. Industry domains include bio and new materials, medical technologies and life sciences, imaging and optics, IoT and electronics, robotics,software & ICT and AI. In addition, Voima Ventures has invested in more than 30 deep tech startups, including companies like Solar Foods, Infinited Fiber Company, and Dispelix. Cornerstone investors are VTT Technical Research Centre of Finland and European Investment Fund (EIF), backed by Finnish private and institutional investors.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Artificial Intelligence
  • Stage:Seed, Pre-Seed, Series A
  • Geography: Finland, Sweden, Norway

Investor stats

  • Total investments: 59
  • Round size: Seed $1M–$5.9M; Pre-Seed $439k–$2.1M; Series A $3.9M–$30M
  • Lead/follow: 64% lead, 36% follow

Portfolio highlights

  • Nucu — The Nucu Pad is a multisensory baby pad that soothes your baby to sleep with womb-like feelscapes.
  • Adamant Health — Adamant Health’s unique technology to analyse Parkinson’s disease symptoms is based on over 15 years of academic research at the University of Eastern Finland. With the technology, clinicians have several days detailed visibility to the patient’s symptoms and is able to optimise the treatment accordingly. Pharma companies benefit from the objectiveand long-term RW data in their clinical and post market studies and can utilise it as complementary diagnostics tool for personalised medication.
  • Sofi Filtration — Innovation in Industrial Liquid Filtration
Show all investments...

Karolinska
VC Fund · Solna, Stockholms Lan, Sweden · 4 investments in Sweden Biotechnology startups

Karolinska Development aims to create value for patients, researchers, investors and society by developing innovations from world class science into products that can be sold or out-licensed with high returns. The business model is to: SELECT the most commercially attractive medical innovations; DEVELOP innovations to the stage where the greatestreturn on investment can be achieved; and COMMERCIALIZE the innovations through the sale of companies or out-licensing of products.Karolinska Development has developed a well-structured selection process to identify the most commercially attractive medical innovations screened by KIAB. Pharmaceutical development is a high-risk enterprise. In most cases, development projects fail because of side effects or insufficient efficacy. Successful selection of innovations is fundamental to Karolinska Development’s business model, which makes the inflow of new projects crucial. One key to success lies in selecting those innovations that can be developed from scientific findings to products and have significant commercial potential. To date, over 1,300 projects have been screened by KIAB.The portfolio companies are often founded together with the innovators and are initially operated as virtual companies with few or no employees. During the first six to twelve months, the companies normally have minimal fixed costs and technological development is outsourced.The innovator, who is often employed at an academic institution, normally participates as a board member and scientific advisor. The CEO of a portfolio company cooperates closely with a representative of Karolinska Development, who in most cases is also a board member of the company. The companies are capitalized to reach their next milestone, usually within a period of six to eighteen months. Development projects are continuously monitored, and those that do not meet their stipulated targets are discontinued. In the first three to four years, a portfolio company’s operating expenses are often limited to a few million Swedish kronor per year, which cover the cost of external studies and the salary of the staff. In subsequent years, Karolinska Development and other investors play an important role recruiting key expertise to the companiesKarolinska Development intends to realize value by exiting portfolio companies or through out-licensing of projects. Such transactions (especially out-licensing) are often structured as single upfront payments followed by payments based on predetermined milestones and royalties on sales. Although Karolinska Development has a flexible exit strategy, pharmaceutical products are, for two reasons, preferably exited at Phase II. First a successful Phase II study indicates that the pharmaceutical has an effect on patients, which is an important value-enhancing factor when negotiating out-licensing or sales. Secondly, finalizing product development and undertaking Phase III clinical trials frequently requires very large patient populations. In many cases this requires much greater resources than those available at Karolinska Development but these can be found in established pharmaceutical companies. Several licensing deals were closed in 2011 involving projects with a similar focus and development phase to Karolinska Development's projects.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Pharmaceutical
  • Stage:Seed, Series A
  • Geography: Sweden, Denmark, United States

Investor stats

  • Total investments: 32
  • Round size: Series A $1.3M–$73M
  • Lead/follow: 34% lead, 66% follow

Portfolio highlights

  • BOOST Pharma — Boost Pharma: Developing a stem cell therapy for Osteogenesis Imperfecta.
  • Modus Therapeutics — Modus Therapeutics is a Swedish drug development company developing sevuparin – a novel drug to treat people suffering from Sickle Cell Disease – a painful, inherited blood disorder affecting millions of people around the globe.
  • Umecrine Cognition — Umecrine Cognition is a Swedish clinical-stage pharmaceutical company developing a novel class of drugs to treat neurological disorders of the brain.
Show all investments...

Norrsken VC
VC Fund · Stockholm, Stockholms Lan, Sweden · 4 investments in Sweden Biotechnology startups

We are a venture capital fund investigating in Start-Ups solving the worlds biggest problems while building massive businesses.

Show more...

Investment focus

  • Industry: Software, Artificial Intelligence, Health Care
  • Stage:Seed, Series A
  • Geography: Sweden, United Kingdom, Germany

Investor stats

  • Total investments: 106
  • Round size: Seed $1.1M–$14M; Series A $4.2M–$56M
  • Lead/follow: 31% lead, 69% follow
  • Last fund: Likely still investing — raised $340M in 2024

Portfolio highlights

  • Biorce — Biorce is an innovating HealthAI startup committed to transforming drug development through the use of artificial intelligence.
  • CEEZER — CEEZER is the digital infrastructure to give companies access to the complex voluntary carbon market. Deliver true climate impact now!
  • Endra — Endra is a software platform for mechanical, electrical, and plumbing (MEP) engineering that automates the design, modeling, and documentation of building systems. The platform generates 2D and 3D models, calculations, schedules, diagrams, and other engineering documentation from architectural and building design inputs. It supports disciplinessuch as electrical, fire alarm, HVAC, plumbing, and sprinkler system design, and integrates with Autodesk Revit and common CAD and BIM file formats. Endra uses artificial intelligence, simulation, and computational methods to assist with tasks such as system layout, cable routing, device placement, and documentation generation while helping engineers comply with applicable design standards and regulations. The platform is designed for MEP engineers and engineering firms seeking to reduce manual design and documentation work across construction projects.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
BackingMinds
VC Fund · Stockholm, Stockholms Lan, Sweden · 3 investments in Sweden Biotechnology startups

We help great minds unleash their full potential!

Show more...

Investment focus

  • Industry: SaaS, Energy, Software
  • Stage:Seed, Pre-Seed
  • Geography: Sweden, Denmark, Finland

Investor stats

  • Total investments: 35
  • Round size: Seed $772k–$3.7M; Pre-Seed $826k–$8.2M
  • Lead/follow: 63% lead, 37% follow
  • Last fund: Likely still investing — raised $53M in 2022

Portfolio highlights

  • Tavion — Tavion is a developer of battery energy storage systems that is expediting Europe's shift to renewable energy. Tavion creates and runs utility-scale BESS infrastructure to improve grid flexibility, stabilize intermittent renewable power, and promote energy independence in European markets.
  • CemVision — CemVision is an industrial tech company that has been developing CO2-free cement.
  • Helios Innovations — Helios Innovations is an industrial machinery manufacturing industry that develops modular and electrical evaporation plants for water.
Show all investments...

I Love Lund
VC Fund · Lund, Skane Lan, Sweden · 3 investments in Sweden Biotechnology startups

I Love Lund is a venture capital firm.The firm seeks opportunities to invest in pre-seed rounds

Show more...

Investment focus

  • Industry: Biotechnology, Medical, Software
  • Stage:Venture - Series Unknown, Pre-Seed, Seed
  • Geography: Sweden

Investor stats

  • Total investments: 7
  • Round size: Pre-Seed $420k–$456k; Venture - Series Unknown $38k–$2.2M
  • Lead/follow: 43% lead, 57% follow

Portfolio highlights

  • Cyclicor — Cyclicor is an innovations based company focused on the development and commercialisation of safer and more sustainable polymers. The company was registered in October of 2012 as a spin-off company from the University of Lund in Sweden and began commercial development of its first product Cycli-ClearTM, a bisphenol free polycarbonate, in late 2013.
  • Katam Technologies — Development of drone measurement and cloud-based evaluation service providing high precision forestry data using a mobile phone or drone.
  • Valkyr Defense Systems — Valkyr specializes in cost-effective, modular, and autonomous defense systems, leveraging commercial off-the-shelf (COTS) technology to fast-track production.
Show all investments...

EIR Ventures
VC Fund · Stockholm, Stockholms Lan, Sweden · 3 investments in Sweden Biotechnology startups

EIR Ventures is a new Life Science Venture Group in the Nordics.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Therapeutics
  • Stage:Series A, Seed
  • Geography: Denmark, Sweden, United States

Investor stats

  • Total investments: 13
  • Round size: Series A $20M–$73M
  • Lead/follow: 54% lead, 46% follow
  • Last fund: Likely still investing — raised $143M in 2021

Portfolio highlights

  • Henlez — Henlez is a Danish startup company.
  • Synklino — Synklino is a developer of a CMV-specific immunotoxin intended to eradicate the cytomegalovirus infection. The company's immunotoxin is highly effective, potent and fast-acting that kills lytic and latently infected cells, enabling patients to have long-term health benefits for transplantation.
  • Galecto — Damora Therapeutics is working to fundamentally redefine care for people with blood disorders by bringing forward optimized therapies that dramatically improve patient outcomes.
Show all investments...

Crowberry Capital
VC Fund · Reykjavík, Gullbringusysla, Iceland · 3 investments in Sweden Biotechnology startups

Crowberry Capital invests at seed and early stage in emerging technology ventures in the Nordics. Our mission is to back people that are good for companies and build companies that are good for people. We have a strong follow-through philosophy and commit to putting your company first.

Show more...

Investment focus

  • Industry: Software, Gaming, Health Care
  • Stage:Seed, Series A, Pre-Seed
  • Geography: Iceland, Denmark, Finland

Investor stats

  • Total investments: 49
  • Round size: Seed $1.6M–$4.2M; Pre-Seed $1k–$1.3M; Series A $5.7M–$17M
  • Lead/follow: 49% lead, 51% follow
  • Last fund: Likely still investing — fund raised in 2021

Portfolio highlights

  • Quanscient — We are building next generation simulation software-as-a-service utilizing Quantum computing algorithms. Our specialty domain of simulations is Computational Electromagnetics.
  • Hemi Health — Hemi Health is a Danish digital-first headache and migraine clinic specializing in diagnosis, personalized treatment, and care for headaches using technology like an app for symptom tracking and video consultations.
  • Augmented Hearing — Augmented Hearing is creating game-changing technology that will be used in fields such as voice assistants, hearing health, environmental noise suppression in phone calls, and many more.
Show all investments...

Inventure
VC Fund · Helsinki, Southern Finland, Finland · 3 investments in Sweden Biotechnology startups

Since 2005, Inventure has backed over 90 companies including Wolt, Swappie, Jobbatical, aiMotive, and more.

Show more...

Investment focus

  • Industry: Software, Information Technology, Health Care
  • Stage:Seed, Series A, Series B
  • Geography: Finland, Sweden, United States

Investor stats

  • Total investments: 172
  • Round size: Seed $549k–$5.9M; Series A $1.3M–$17M; Series B $1.3M–$25M
  • Lead/follow: 46% lead, 54% follow
  • Last fund: Likely still investing — raised $169M in 2022

Portfolio highlights

  • Finch — Optimize building design with AI and graph technology. Get immediate feedback on performance, detect errors and find optimal solutions.
  • ONEiO — ONEiO is a cloud-native integration service provider connecting people, processes, and tools – enabling seamless collaboration without traditional integration hassle. Provided as a turn-key solution, as self-service, or something in between. You choose.
  • Valuebeat — Grow your culture. Backed by data. Platypus is the HR and recruitment tool that measures cultural drivers of people across the organization to help you qualify decisions on hiring and managing your culture.
Show all investments...

Partnerinvest Norr
VC Fund · Piteå, Norrbottens Lan, Sweden · 3 investments in Sweden Biotechnology startups

Partnerinvest Norr is a private equity firm specialized in software, security, and biometrics sectors. Partnerinvest Övre Norrland AB is a venture capital firms that seeks to invest in limited companies which have are in the expansion phase.

Show more...

Investment focus

  • Industry: Software, Manufacturing, Information Technology
  • Stage:Seed, Series A
  • Geography: Sweden, United States

Investor stats

  • Total investments: 67
  • Round size: Seed $588k–$2.1M; Series A $1.5M–$5.3M
  • Lead/follow: 15% lead, 85% follow
  • Last fund: May invest from a new fund soon — last raise in 2009

Portfolio highlights

  • Senseworks — Senseworks is an insight platform that enables colleagues to collaborate effectively with customers by providing a single source of truth for accounting data.
  • Cold River Games — Crystalfall is an upcoming free online action RPG with customizable skills and an endless endgame, set in a steampunk world.
  • Remos Space Systems — Remos Space Systems simplifies satellite ground operations.
Show all investments...

Nordic Science Investments
VC Fund · 2 investments in Sweden Biotechnology startups

We partner with founders to transform unseen scientific discoveries into future breakthroughs, jointly moving businesses, people, and the world forward.

Show more...

Investment focus

  • Industry: Biotechnology, Medical, Health Diagnostics
  • Stage:Seed, Pre-Seed, Series A
  • Geography: Finland, Sweden, United States

Investor stats

  • Total investments: 17
  • Round size: Seed $373k–$4.6M; Pre-Seed $380k–$837k; Series A $2.9M–$3.9M
  • Lead/follow: 88% lead, 12% follow

Portfolio highlights

  • CubaseBio — Cubase Bio is a biotechnology business that focuses on spatial biology tools. It creates solutions for 3D spatial analysis to speed up drug discovery.
  • mu-ray.tech — Mu-ray.tech is focused on advancing the field of medical diagnostics and industrial quality control. mu-ray.tech is developing a groundbreaking technology for the rapid, safe and accurate 3D-imaging of the chemical composition of scanned objects, serving critical needs in industrial quality control and medical diagnostics. The technology is basedon Muon Beam Imaging (MBI), an innovative technology leveraging Laser Plasma Accelerator-based artificial muon sources, new generation particle detector systems and AI. In industry, we are working with the partners in the heavy, aerospace, and defence domains.mu-ray.tech operates at the three sites: DESY in Hamburg (hardware), Tehnopol in Tallinn (algorithms and software), and Bradfield Centre in Cambridge (algorithms, business development). Our main collaboration on the MBI technology partners are GScan in Estonia and UK, DESY in Hamburg, the University of Cambridge, and KBFI in Tallinn.
  • Perfat Technologies — Perfat Technologies is a health-based technology company that develops fat-management applications based on healthy vegetable oils.
Show all investments...

Nina Capital
VC Fund · Barcelona, Catalonia, Spain · 2 investments in Sweden Biotechnology startups, 11 in the past 12 months

We deploy early stage capital to fuel the growth of need-driven health technology companies.

Show more...

Investment focus

  • Industry: Health Care, Artificial Intelligence, Software
  • Stage:Seed, Pre-Seed, Series A
  • Geography: United States, United Kingdom, Germany

Investor stats

  • Total investments: 89
  • Round size: Seed $2M–$6.3M; Pre-Seed $573k–$2.4M; Series A $5M–$21M
  • Lead/follow: 42% lead, 58% follow
  • Last fund: Likely actively investing — fund raised in 2025

Portfolio highlights

  • Navidence — Navidence provides a transformative Real World Evidence (RWE) Design platform that enables organizations to efficiently adapt to the ever-increasing ecosystem of Real World Data (RWD) sources. The company unlocks the power of Computable Operational Definitions (CODefs) for RWE Design and RWD Assessment. Navidence's RWE Sherpa platform offerstools to streamline the process of defining an RWE study's data, making it easier for researchers to conduct their studies in the age of data.
  • Rivia — Integrated Clinical Trial Intelligence. Drive therapeutic evaluation and trial management with real-time insights.
  • Ladder Health — Ladder Health offers virtual pediatric therapy and support for early childhood developmental delays, including speech and physical therapy.
Show all investments...

SEB Venture Capital
VC Fund · Stockholm, Stockholms Lan, Sweden · 2 investments in Sweden Biotechnology startups

SEB Venture Capital is a Fintech investor that helps entrepreneurs and innovators launch and grow profitable businesses. They primarily serve as a strategic corporate venture focused on Fintech investments, with the option of partnering with SEB. They are also on the hunt for game-changing inventive solutions to new technologies that will make thefinancial industry smarter, safer, and more environmentally responsible, as well as more user-friendly. They also function as an evergreen fund, giving them the flexibility and staying strength to focus on long-term wealth development depending on what is best for the firm and its shareholders.

Show more...

Investment focus

  • Industry: Software, Information Technology, FinTech
  • Stage:Series A, Series B
  • Geography: Sweden, Denmark, United Kingdom

Investor stats

  • Total investments: 70
  • Round size: Series A $1.2M–$11M; Series B $2.2M–$23M
  • Lead/follow: 41% lead, 59% follow
  • Last fund: May invest from a new fund soon — raised $300M in 1995

Portfolio highlights

  • Apica — The Operational Data Fabric from Apica unifies and connects all your data using a revolutionary Active Observability architecture.
  • MobileTag — Mobile Tag, the European leader in mobile barcode solutions, continues to innovate with the launch of its latest application: mobiletag Universal Reader and shopping.Mobile Tag is behind the creation of the flashcode, the standard 2D barcode used by operators in France. This type of Datamatrix barcode is used by the biggest companies indisplay, transportation, distribution, the pharmaceutical industry, and more.Mobile Tag has always tried to develop new technology from the consumer's point of view, and the mobiletag Universal Reader & shopping is no exception.The concept behind this application is to send, receive and share information and best prices to everyone and for everyone through all standardized barcodes.Scanning a barcode with your mobile phone is simply taking a picture of it with your phone, using the mobiletag application. Mobile tag is free!
  • CorPower Ocean — CorPower Ocean AB was founded in 2009 to develop high efficiency Wave Energy Converters (WECs).CorPower's Wave Energy Converters deliver five times higher annual energy output per ton of device compared to previously known wave power solutions. The step-change improvement in performance and efficiency allows a Cost-of-Energy that cancompete with offshore wind. The products are currently in pilot with Iberdrola. CorPower has assembled a team with extensive experience in energy generation, design and manufacturing of production equipment, system engineering as well as the market expertise to allow us to continue transforming the technology of tomorrow into renewable energy applications of today.
Show all investments...

Noaber
VC Fund · Lunteren, Gelderland, The Netherlands · 2 investments in Sweden Biotechnology startups

Noaber Ventures invests in initiatives that bring social transformations using information technology.

Show more...

Investment focus

  • Industry: Health Care, Medical, Fitness
  • Stage:Seed, Series A
  • Geography: The Netherlands, Israel, Germany

Investor stats

  • Total investments: 19
  • Round size: Seed $1.3M–$6.3M; Series A $3M–$20M
  • Lead/follow: 21% lead, 79% follow

Portfolio highlights

  • Plasmacure — Plasmacure develops innovative plasma technology for wound care. Discover how cold plasma is transforming the treatment of chronic wounds.
  • Mirantus Health — Mirantus is building a distributed healthcare provider to improve access to care for underserved patients. Through healthcare services (Mirantus Care) and cloud-solutions (Mirantus OS), Mirantus empowers doctors to efficiently treat patients who were difficult to reach before. This improves healthcare access for patients, allows physicians to earnmore, while saving payors billions in downstream costs. Mirantus is on a mission to get every specialist physician in Europe to participate in distributed healthcare, to improve healthcare access for 100M+ underserved patients.
  • Alba Health — Discover your baby's gut health & microbiome for the best start in life.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
LU Holding
VC Fund · 2 investments in Sweden Biotechnology startups

LU Holding is a Lund University’s investment company.

Show more...

Investment focus

  • Industry: Biotechnology, Software, Medical Device
  • Stage:Seed, Pre-Seed
  • Geography: Sweden

Investor stats

  • Total investments: 3
  • Lead/follow: 33% lead, 67% follow

Portfolio highlights

  • MedVasc — MedVasc has developed Solution a patented medical device that reduces pain when treating varicose veins.
  • Bionamic — Bionamic provides solutions for the analysis of life science data to reduce or eliminate the manual steps between raw data and results.
  • Trackpaw Scientific — Contributing to the development of safe and effective pharmaceuticals at increased speed and quality by digitalising the preclinical study landscape.
Show all investments...

Boehringer Ingelheim Venture Fund
VC Fund · Ingelheim Am Rhein, Rheinland-Pfalz, Germany · 2 investments in Sweden Biotechnology startups

Discover Boehringer Ingelheim Venture Fund. We invest in groundbreaking science to transform care. Explore our mission and join us in advancing medicine

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Therapeutics
  • Stage:Series A, Series B, Seed
  • Geography: United States, Germany, Switzerland

Investor stats

  • Total investments: 101
  • Round size: Seed $1.8M–$20M; Series A $3.8M–$34M; Series B $11M–$50M
  • Lead/follow: 48% lead, 52% follow
  • Last fund: May invest from a new fund soon — raised $250M in 2018

Portfolio highlights

  • Perfood — Perfood is a digital therapeutic startup that identifies what actions need to take on a personalized level, to prevent or fight diseases. Using sensors, lab results, and holistic analyses, they derive therapeutic angles and deliver them in a slick, easy-to-use way, making them accessible for all patients. They call this approach digitaltherapeutics. A digital solution that is just as effective as a drug. But without side effects.
  • ArrePath — ArrePath is an anti-infective drug discovery company addressing the global health challenge of drug resistant infections.
  • Brainomix — Since launching as a spin-out from the University of Oxford in 2010, Brainomix has developed award-winning, AI-powered imaging biomarkers, assisting physicians across the world to make better life-saving decisions. Brainomix seminal product, e-Stroke is a collection of tools that use state-of-the-art AI algorithms to support doctors by providingreal-time interpretation of brain scans to help guide treatment and transfer decisions for stroke patients, allowing more patients to get the right treatment, in the right place, at the right time.
Show all investments...

Life Science Invest
VC Fund · Bromma, Stockholms Lan, Sweden · 2 investments in Sweden Biotechnology startups

LSI Academy - New education 2026, read more here

Show more...

Investment focus

  • Industry: Medical, Biotechnology, Biopharma
  • Stage:Seed, Pre-Seed
  • Geography: Sweden

Investor stats

  • Total investments: 6
  • Round size: Seed $682k–$4.6M; Pre-Seed $310k–$500k
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Haga Bioscience — Haga Bioscience is a biotechnology research company.
  • CubaseBio — Cubase Bio is a biotechnology business that focuses on spatial biology tools. It creates solutions for 3D spatial analysis to speed up drug discovery.
  • SampleFacts — Next generation Dried Blood Spot sampling – separating cells and plasma at the point of collection.
Show all investments...

Fåhraeus Startup and Growth
VC Fund · Lund, Skane Lan, Sweden · 2 investments in Sweden Biotechnology startups

Fåhraeus Startup and Growth is a venture capital fund that invests early in life science and tech companies.

Show more...

Investment focus

  • Industry: Medical, Biotechnology, Genetics
  • Stage:Seed, Venture - Series Unknown
  • Geography: Sweden, Denmark, Finland

Investor stats

  • Total investments: 9
  • Round size: Seed $772k–$2.7M; Venture - Series Unknown $2M–$5.6M
  • Lead/follow: 44% lead, 56% follow

Portfolio highlights

  • Aplagon — Aplagon is committed to bringing unique, effective antithrombotic medicines with important safety advantages to patients with unmet needs.
  • Fida Biosystems — Quantification and characterisation of complex biology made simple. Study molecular interactions in solution, with only nanoliters of sample. Used by industry leaders.
  • Trackpaw Scientific — Contributing to the development of safe and effective pharmaceuticals at increased speed and quality by digitalising the preclinical study landscape.
Show all investments...

Hadean Ventures
VC Fund · Oslo, Oslo, Norway · 2 investments in Sweden Biotechnology startups

Hadean Ventures is a life science fund manager that invests in life science companies across europe with a particular focus on the nordic region. The funds are backed by leading private and institutional investors. Hadean Ventures has offices in oslo and stockholm and collaborates with world-class academic institutions and start-up hubs across theregion

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Series A, Series B
  • Geography: Norway, Sweden, Germany

Investor stats

  • Total investments: 32
  • Round size: Series A $4.3M–$79M; Series B $4.5M–$68M
  • Lead/follow: 44% lead, 56% follow
  • Last fund: Likely still investing — raised $105M in 2021

Portfolio highlights

  • Ribbon Bio
  • Gesynta Pharma — Founded in 2017, Gesynta Pharma bases its R&D on research from the Karolinska Institutet. The most advanced drug candidate, GS-248, reduces inflammation and increases blood flow in the microvasculature, thereby having the potential to provide improved treatments for several serious diseases. In an ongoing clinical proof-of-concept study,GS-248 is being evaluated for its capacity to normalize vascular blood flow and reduce pain in patients with the autoimmune disease systemic sclerosis. Positive results from this study may lead to a rapid broadening of the development program towards additional indications, for example cardiovascular diseases and rheumatic diseases other than systemic sclerosis. Major shareholders include Industrifonden, Linc, Hadean Ventures, and a number of successful life science entrepreneurs. For more information, please visit www.gesynta.se
  • TargED Biopharmaceuticals — TargED Biopharmaceuticals is a biotechnology company that develops first-in-class biological drugs to improve treatment of thrombosis.TargED stands for Targeted Enzyme Delivery. Their biological drugs are unique by using small antibodies (“VhH”) to deliver enzymes to sites of thrombosis, enabling ‘targeted’ thrombolysis.
Show all investments...

ARCH Venture Partners
VC Fund · Chicago, Illinois, United States · 2 investments in Sweden Biotechnology startups

ARCH Venture Partners provides seed / early stage venture capital for technology firms in information technology, life sciences, and physical sciences

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Therapeutics
  • Stage:Series A, Series B, Series C
  • Geography: United States, China, United Kingdom

Investor stats

  • Total investments: 414
  • Round size: Series A $8.4M–$213M; Series B $14M–$250M; Series C $15M–$175M
  • Lead/follow: 30% lead, 70% follow
  • Last fund: Likely actively investing — fund raised in 2024

Portfolio highlights

  • Synchron — The endovascular brain computer interface.
  • Parabilis Medicines — Parabilis Medicines is a biopharmaceutical company in the clinical stage that focuses on developing exceptional medications targeting challenging protein structures previously deemed undruggable. Utilizing more than ten years of exclusive data, innovative laboratory techniques, and algorithms based on AI and physics, the company has introduced anovel category of stabilized, cell-penetrating alpha-helical peptides known as Helicons™. These peptides can modulate intracellular proteins that traditional drug modalities cannot reach.
  • HI-Bio — HI-Bio leverages human genetic and immunological insights to deliver targeted, effective medicines to patients with immune-mediated diseases.
Show all investments...

Länsförsäkringar
VC Fund · Stockholm, Stockholms Lan, Sweden · 2 investments in Sweden Biotechnology startups

Länsförsäkringar is a Swedish group of public insurance companies.

Show more...

Investment focus

  • Industry: Real Estate, Biotechnology, Manufacturing
  • Stage:Seed, Pre-Seed
  • Geography: Sweden

Investor stats

  • Total investments: 12
  • Round size: Seed $484k–$1.1M
  • Lead/follow: 17% lead, 83% follow

Portfolio highlights

  • Stendorren Fastigheter — Stendorren Fastigheter is a company involved in the real estate industry. It develops, owns, operates, and maintains industrial, logistical, and warehouse facilities. The business offers adequate and suitable space on fair lease terms through its tenant.
  • pixlbio (formerly Phenaros) — Data-centric drug discovery with AI, Phenomics and Automation.
  • Swedish Logistic Property — Swedish Logistic Property (SLP) specializes in the development and management of logistics properties across Sweden. With a focus on energy efficiency, SLP provides modern logistics solutions tailored to meet the needs of various businesses. The company's portfolio includes strategically located properties designed to support efficientlogistics and supply chain operations. SLP also engages in the acquisition and development of new properties, aiming to expand its footprint in the logistics real estate market. The company's commitment to sustainability is evident in its construction practices and the operation of its logistics facilities.
Show all investments...

Faro Capital
VC Fund · Buenos Aires, Distrito Federal, Argentina · 2 investments in Sweden Biotechnology startups

FARO is an Argentina company over 10 years of experience in the development and operation of integrated projects in the agribusiness sector. All projects FARO own position it as a reference and leader both locally and internationally.Among his various projects, FARO operates the largest tree planting pecan nut Latin America, with projection tobecome the largest southern hemisphere and one of the largest in the world. This project is structured under different vehicles, including Alto Pecan stands, the first real estate development of nautical fields planted with pecan nut Latin America, located in Villa Paranacito, Entre Ríos . Another project is AgroConsortium, productive trust for the production and marketing of cereals and oilseeds in leased farms located in different productive areas in Argentina and potentially in the region. Finally, thanks to the expertise acquired in agribusiness, FARO developed his own business model for productive land conversion. Its aim is to position rural properties whose productive potential is not reflected in the price and complement the cycle with the economic use of land in intensive production, short and medium term.Since 2006, the Investor Group is a strategic partner OMBU FARO for all investment portfolios development ventures related to agribusiness, that focus on supply both local and international markets.

Show more...

Investment focus

  • Industry: Biotechnology, Gaming, Medical
  • Stage:Series A, Seed
  • Geography: Sweden, United States

Investor stats

  • Total investments: 5
  • Round size: Series A $2.2M–$25M
  • Lead/follow: 20% lead, 80% follow
  • Last fund: May invest from a new fund soon — last raise in 2014

Portfolio highlights

  • Bionamic — Bionamic provides solutions for the analysis of life science data to reduce or eliminate the manual steps between raw data and results.
  • Bluwhale — Unlock Web3 Wallet Potential with AI Insights. Supercharge Your Business Growth
  • IntuiCell — IntuiCell develops a fundamentally new recursive computing architecture and associated technology platform.
Show all investments...

Flerie Invest
VC Fund · 2 investments in Sweden Biotechnology startups

Flerie is an active long-term life science investor, focusing on biotech and pharmaceutical investments globally.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Pharmaceutical
  • Stage:Series A, Series B
  • Geography: Sweden, United States, United Kingdom

Investor stats

  • Total investments: 22
  • Round size: Series A $2.5M–$21M; Series B $12M–$75M
  • Lead/follow: 50% lead, 50% follow

Portfolio highlights

  • Nanologica — Nanologica combines unique know-how in the field of materials technology with a genuine interest in solving real problems in life science. The company works with nanoporous silica which has properties that are attractive in a wide variety of applications. In order to succeed, development work is carried out in close dialog with customers.Nanologica is unique in that it is a world leader in controlling the form, type of porosity and surface area of particles of silica. This competence can be used to produce particles that have the potential to solve problems in diverse application areas. The company’s core competency has been developed and expanded in twoareas of application in particular: drug delivery on the one hand and on the other chromatography, a technology used for the separation and purification of products on the market and in development.The starting point for Nanologica’s work is the material sciences, a field in which the company’s founder has developed and patented completely new materials. The initial research was based at Stockholm University and the Ångström laboratories atUppsala University.
  • KAHR medical — KAHR Medical ("KAHR") is pioneering the development of "third generation biological drugs," a unique class of proprietary fusion-protein molecules with clear and far-reaching advantages. KAHR's technology represents a paradigm shift in protein-based pharmaceuticals that will significantly expand available treatment optionsfor cancer and autoimmune disorders.
  • XNK Therapeutics — XNK Therapeutics, founded in 2012, is one of the pioneering companies within the landscape of cell therapy.
Show all investments...

Segulah Medical Acceleration
VC Fund · Stockholm, Stockholms Lan, Sweden · 2 investments in Sweden Biotechnology startups

Segulah Medical Acceleration is a Scandinavia-based investment company focusing on innovative medical technology companies in Europe.

Show more...

Investment focus

  • Industry: Health Care, Medical Device, Biotechnology
  • Stage:Series A, Series D, Series B
  • Geography: Sweden, Germany, United States

Investor stats

  • Total investments: 6
  • Round size: Series A $8.7M–$10M
  • Lead/follow: 83% lead, 17% follow

Portfolio highlights

  • Protembis — ProtEmbo is designed to be a simple and reliable solution for one of the most feared complications during TAVR.The advent of transcatheter treatments for valvular heart disease has been a major revolution in the care of patients with disabilities or intercurrent illnesses that precluded undergoing stressful open cardiac surgical procedures.Nonetheless, in spite of ongoing improvements in TAVR procedures and outcomes, the occurrence of cerebrovascular events represents a significant morbidity of TAVR.Protembis was founded based on the vision to reduce the risk of cerebrovascular events, thereby improving outcomes and making TAVR even safer – especially in light of TAVR shifting to younger and lower-risk patients. The ProtEmbo System is an adjunctive device used during TAVR and removed following completion of valve implantation. The ProtEmbo is an intra-aortic filter device that is designed to deflect embolic material arising during TAVR away from the cerebral circulation.
  • Navinci Diagnostics — Navinci is a Swedish biotech company specializing in innovative in situ proximity ligation assay-based solutions for spatial proteomics.
  • Collective Minds — Collective Minds develops and delivers a cloud-based collaboration platform for healthcare and research with access to data, human and digital expertise.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
LIU Invest
VC Fund · Linköping, Ostergotlands Lan, Sweden · 2 investments in Sweden Biotechnology startups

LIU invests in companies that are based on projects and ideas from Linköping University. LIU Invest is focused on investments in early phases. Investments are typically 250 000, but can be doubled by an additional investment.

Show more...

Investment focus

  • Industry: Biotechnology, Information Technology, AgTech
  • Stage:Seed, Pre-Seed
  • Geography: Sweden

Investor stats

  • Total investments: 9
  • Round size: Seed $579k–$1.4M; Pre-Seed $88k–$282k
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Cellfion — Cellfion provides sustainable materials for next level clean energy storage and conversion devices.​
  • Sonicflora — Plants have always been speaking. We can now understand them.
  • Polar Light Technologies — Polar Light Technologies focuses on developing the next generation of Nano and micro LED technology.
Show all investments...

LifeArc Ventures
VC Fund · London, England, United Kingdom · 1 investments in Sweden Biotechnology startups

LifeArc Ventures a self-funding medical research charity that invests in Seed and Series-A stage Biotech and Healthtech companies.

Show more...

Investment focus

  • Industry: Health Care, Fitness, Wellness
  • Stage:Series A, Seed
  • Geography: United Kingdom, United States

Investor stats

  • Total investments: 9
  • Lead/follow: no public data

Portfolio highlights

  • GlycoEra — GlycoEra is a CustomGlycan platform that unlocks the power of glycan-mediated biology to develop a pipeline of novel biologics.
  • Affect — Get addiction and mental health treatment through an app that offers a full outpatient program, complete with medications and therapy.
  • Tribune Therapeutics — Tribune Therapeutics is a preclinical biopharmaceutical company building a promising pipeline of novel medicines to treat patients with a wide range of fibrotic diseases. It was founded in 2020 with funding from HealthCap and Novo Seeds.
Show all investments...

Teknoinvest
VC Fund · Oslo, Oslo, Norway · 1 investments in Sweden Biotechnology startups

Teknoinvest is a premier Scandinavian venture capital company. They invest in areas of emerging technologies within the ITC and Life Sciences sectors. Their main geographical scope is Scandinavia and the USA. Teknoinvest was established as the first venture capital investment company. Teknoinvest is one of the most successful VC´s in Scandinaviaaccording to track record of value created for their investors.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Medical
  • Stage:Series B, Series A
  • Geography: Sweden, Norway, United States

Investor stats

  • Total investments: 23
  • Lead/follow: no public data

Portfolio highlights

  • GLO — glō is a venture-backed company focused on the development and commercialization of advanced LED display products using nanotechnology. The unique nanotechnology is based on 11 years of research at Lund University’s Nanometer Structure Consortium. Headed by Professor Lars Samuelson, one of the world’s leading scientists in this field, who haspublished more than 500 papers related to this technology.glō's first office is in Lund, Sweden, where basic material research continues for the next generation nanotechnology. glō's research and product development along with pilot fabrication operation is carried out at glō-USA in Sunnyvale, California. In 2016, glō established an Asia office in Taipei, Taiwan, one of the largest and fastest-growing regions for LED lighting and display applications.glō's technology sidesteps the technical limitations of current planar LED technology. It allows for the creation of highly efficient, stable and ultimately unique red, green, blue (RGB) emitters out of one material system. It aims to achieve the industry’s best color stability and ultimately enables the growth of red, green and blue emitters on the same wafer. Highly-efficient white LEDs with high color rendering will be possible without the need for phosphor conversion. It is the next enabling technology for advanced display, illumination and automotive applications.glō nanowire light-emitting diodes (nLEDs) are based on its proprietary hetero-structured semiconductor nanowire epitaxial growth and process technologies for which standard manufacturing equipment and materials can be utilized.glō currently holds over 175 patents across US, Europe and Asia. These patents are not subject to any cross-licensing with the LED oligopoly. The glō team is constantly strengthening its intellectual property position in this technology and related applications.
  • SantoSolve — SantoSolve is developing topical analgesic products based on non-radioactive strontium as the active substance. The Development program was initiated based on experimental clinical use of strontium-based products showing evidence of strong local analgesic effects on several localized pain conditions of both nociceptive and neuropatic origin. Nosignificant adverse effects associated with the treatment was reported.The company’s lead product, 2PX, is topically administered, utilizing dermal penetration enhancers for delivery of the active agent to its subdermal site of action. Phase I safety and pharmacology studies showed the active agent to have low systemic bioavailability, and only few and minor adverse effects were observed at the site of administration. In open label Phase II clinical trials, the product has shown strong analgesic effect in both nociceptive and neuropatic pain conditions. In follow up, placebo controlled trials, the analgesic effect of the product has been further documented. In the company’s most advanced pain indication under study, osteoarthritis, the company has recently completed the Phase II program.These trials supports the open label results and document statistically that the analgesic effect in patients treated with 2PX is superior to that observed with placebo treatment.
  • Sol Voltaics — Founded in 2007, Sol Voltaics AB is a venture-backed, development-stage nanotechnology company focused on development and commercialization of highly efficient, third-generation photovoltaic concentrator solar cells based on its proprietary heterostructured nanowire epitaxial growth and process technologies.
Show all investments...

Inven2
VC Fund · Oslo, Oslo, Norway · 1 investments in Sweden Biotechnology startups

Inven2 specializes in the commercialization of research and to make outstanding research into the industry of the future.

Show more...

Investment focus

  • Industry: Therapeutics, Biotechnology, Pharmaceutical
  • Stage:Series A
  • Geography: Sweden

Investor stats

  • Total investments: 1
  • Lead/follow: no public data

Portfolio highlights

  • Tribune Therapeutics — Tribune Therapeutics is a preclinical biopharmaceutical company building a promising pipeline of novel medicines to treat patients with a wide range of fibrotic diseases. It was founded in 2020 with funding from HealthCap and Novo Seeds.
Show all investments...

Social Starts
VC Fund · San Francisco, California, United States · 1 investments in Sweden Biotechnology startups

Social Starts is a $60M+ venture capital partnership with a uniquely data-driven approach to investing in moment-of-inception and Series A financing rounds.

Show more...

Investment focus

  • Industry: Software, Health Care, Artificial Intelligence
  • Stage:Seed, Series A
  • Geography: United States, Germany, United Kingdom

Investor stats

  • Total investments: 288
  • Lead/follow: no public data

Portfolio highlights

  • Hey Jane — Get safe, effective and affordable abortion pills delivered fast to your home. Hey Jane is the first digital abortion clinic, connecting you to licensed providers in your state through telemedicine.
  • Mae Health — Mae is a maternal health platform that connects expectant mothers with critical resources to drive positive pregnancy outcomes.
  • Wayfinder Biosciences — We design RNA for next generation biomanufacturing and smart therapeutics.
Show all investments...

Impilo
VC Fund · Stockholm, Stockholms Lan, Sweden · 1 investments in Sweden Biotechnology startups

Impilo is a Nordic investment company focused solely on investments in companies operating in the pharmaceutical, medical technology, healthcare services and other health-related industries. Its starting point is that our portfolio companies must contribute to a positive and sustainable development of the communities and markets in which theyoperate in order to remain successful in the long term. It was founded in 2017 and is based in 2017 and is based in Stockholm, Sweden.

Show more...

Investment focus

  • Industry: Biotechnology, Pharmaceutical, Medical
  • Geography: Sweden, Denmark

Investor stats

  • Total investments: 3
  • Lead/follow: no public data

Portfolio highlights

  • Cavidi — Cavidi is Sweden’s leading supplier of viral load for HIV monitoring. Cavidi’s products enable efficient management of anti-HIV drugs (ARV therapy) so that people living with HIV can live a normal lifespan. Cavidi’s diagnostics reduce the cost of treatment and the spread of HIV. Cavidi also provides tools and kits for virus research to many of theworld’s leading labs.Cavidi is a Swedish biotech company founded as a spin-off from Uppsala University. Their expertise is based on understanding viruses and using this knowledge to create research tools and clinical diagnostics. Today their focus is on HIV but our methods and expertise can be applied to other viruses.Cavidi’s head office is in Uppsala, Sweden and they have sales offices in South Africa, India and USA. Their customers include hospitals, patient clinics, private laboratories, the pharmaceutical industry and research institutions worldwide.
  • Scantox — Since 1977 Scantox has been a trusted partner for in-vivo preclinical research services for the pharmaceutical and medical device industries.
  • Pelago Bioscience — Pelago Bioscience offers target engagement studies of drug candidate interactions with target proteins in cells and tissues.
Show all investments...

Monesi
VC Fund · 1 investments in Sweden Biotechnology startups

Monesi is an invesment firm.

Show more...

Investment focus

  • Industry: Life Science, Biotechnology
  • Stage:Pre-Seed
  • Geography: Sweden

Investor stats

  • Total investments: 1
  • Lead/follow: no public data

Portfolio highlights

  • Phenaros Pharmaceuticals — Data-centric drug discovery with AI, Phenomics and Automation.
Show all investments...

HJKK Didrikson
VC Fund · 1 investments in Sweden Biotechnology startups

HJKK Didrikson operates as an investment firm.

Show more...

Investment focus

  • Industry: Biopharma, Biotechnology, Pharmaceutical
  • Stage:Seed
  • Geography: Sweden

Investor stats

  • Total investments: 1
  • Lead/follow: no public data

Portfolio highlights

  • AAX Biotech — AAX Biotech specializes in next-generation antibody therapeutics through our two unique and proprietary technologies, Seqitope™ and Opti-mAb™, that enable high-resolution and high throughput epitope mapping as well as stabilization of single chain variable fragments (scFv) for applications such as bispecific antibodies and CAR-T cells. OurTechnologies: Seqitope™ is a high-resolution, high throughput method for antibody epitope mapping that accelerates the development of efficacious therapeutics.Opti-mAb™ is a new scFv format with dramatically improved expression levels and reduced aggregation tendencies. This will significantly improve the next generation of cutting-edge immunotherapies such as CAR-T and bispecific antibodies.
Show all investments...

Phase2Phase Biopharma
VC Fund · Stockholm, Stockholms Lan, Sweden · 1 investments in Sweden Biotechnology startups

Phase2Phase Biopharma is a consulting company that offers CMC strategies, CRO, CMO, CDMO sourcing, CMC project management, and QA services.

Show more...

Investment focus

  • Industry: Biopharma, Biotechnology, Pharmaceutical
  • Stage:Seed
  • Geography: Sweden

Investor stats

  • Total investments: 1
  • Lead/follow: no public data

Portfolio highlights

  • AAX Biotech — AAX Biotech specializes in next-generation antibody therapeutics through our two unique and proprietary technologies, Seqitope™ and Opti-mAb™, that enable high-resolution and high throughput epitope mapping as well as stabilization of single chain variable fragments (scFv) for applications such as bispecific antibodies and CAR-T cells. OurTechnologies: Seqitope™ is a high-resolution, high throughput method for antibody epitope mapping that accelerates the development of efficacious therapeutics.Opti-mAb™ is a new scFv format with dramatically improved expression levels and reduced aggregation tendencies. This will significantly improve the next generation of cutting-edge immunotherapies such as CAR-T and bispecific antibodies.
Show all investments...

Inter Ikea
VC Fund · Luxembourg, Luxembourg, Luxembourg · 1 investments in Sweden Biotechnology startups

Inter IKEA Group's aim is to secure continuous improvement, development, expansion and a long life of the franchising operation.

Show more...

Investment focus

  • Industry: Software, Furniture, Health Care
  • Stage:Seed, Corporate Round
  • Geography: Germany, Sweden, Denmark

Investor stats

  • Total investments: 4
  • Lead/follow: no public data

Portfolio highlights

  • nyris — Our custom search engines make it easy for people to find products, spare parts, and components for industry and eCommerce
  • NORNORM — High quality pre-loved office furniture, including office design, installation and flexibility to change. Own less, pay less, and change whenever.
  • Seprify — Enabling sustainable products
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Ackra Invest
VC Fund · Skellefteå, Vasterbottens Lan, Sweden · 1 investments in Sweden Biotechnology startups

Ackra Invest AB is a venture capital and private equity firm specializing in late venture, growth capital and turnaround investments. The firm does not have a sector preference and seeks to invest in small and middle sized companies based in Norrland; the Northern region of Sweden. It does not provide loans or invest in seed or early venture. Thefirm takes minority stakes, between 10 percent and 49 percent and invests between SEK1 million ($0.13 million) and SEK8 million ($1.02 million). It invests in equity or convertible loans and can perform co-investments. The firm seeks to exit its investments within seven years. Ackra Invest AB was founded in 2005 and is based in Skellefteå, Sweden.

Show more...

Investment focus

  • Industry: Manufacturing, Mining, Chemical
  • Stage:Seed
  • Geography: Sweden

Investor stats

  • Total investments: 5
  • Lead/follow: no public data

Portfolio highlights

  • Xore — Xore AB has develops and sells analyzers to enrichment plants in the mining industry.Xore is one of the world’s leading suppliers of on-stream analyzers and related services to the mining industry. Xore is the natural first choice when investing in equipment for on-stream analysis of pulp and liquids. Our product brand is Boxray™. Xore is agenuine Swedish engineering technology company based in Skellefteå in northern Sweden.
  • Protab AB — Protab specializes in machining, turning and milling and manufactures details for the hydraulic and forest industry. Another important part of the business is system delivery, where the company also assembles the details that were manufactured.Protab manufactures components primarily for the hydraulics and forestry industries. System deliveries,where the company assembles manufactured components, form another important part of the operation. We also do value flow analyses to improve the efficiency of our customers' businesses. How can we make things better for you?
  • Fortlax AB — Fortlax is Northern Sweden's data center with three world-class facilities just outside Piteå. We help companies grow using smart IT and cloud services. We store data in highest-class facilities at a location where risk analysis shows extremely low risk of natural disasters. In addition, we operate all our facilities with 100% green energy anduse natural cooling for large parts of the year. Fortlax AB has over the past fiscal year more than tripled its revenue and shows profit.
Show all investments...

Unruly Capital
VC Fund · Italy, Texas, United States · 1 investments in Sweden Biotechnology startups

Investing in the crazy before it becomes normal

Show more...

Investment focus

  • Industry: Biotechnology, CleanTech, Manufacturing
  • Stage:Seed, Pre-Seed
  • Geography: United Kingdom, United States, Germany

Investor stats

  • Total investments: 49
  • Lead/follow: no public data

Portfolio highlights

  • Ephos — Designing and manufacturing glass-based integrated photonic circuits that power the most advanced classical and quantum devices
  • AtmoCooling — AtmoCooling transforms coastal deserts into thriving hubs of agriculture, clean energy, and climate resilience. It was founded in 2022 and operates in the USA and UAE.
  • Terran Robotics — Terran Robotics is a construction company that specializes in AI and robotics. The company's headquarters are in Bloomington, Indiana.
Show all investments...

Leksell Social Ventures
VC Fund · Stockholm, Stockholms Lan, Sweden · 1 investments in Sweden Biotechnology startups

Leksell Social Ventures is the first professional impact investing company in Sweden. LSV seeks to evolve the practice of philanthropy through establishing social impact investing at an institutional scale in Sweden, building on inspiration from the UK and US. We are a non-profit, private investment company incorporated in Sweden. LSVfinances scalable, economically sustainable, well governed initiatives with evidence based and measurable social impact. LSV invests up to 1 mUSD through equity, loans, guarantees or grants. LSV is currently focusing on integration, mental ill health and tech for good initiatives Founded by life-science billionaire Laurent Leksell (Elekta AB) and Family LSV is run by CEO, Hugo Mörse and team.

Show more...

Investment focus

  • Industry: Health Care, Apps, Fitness
  • Stage:Seed, Series B
  • Geography: Sweden, United States

Investor stats

  • Total investments: 6
  • Lead/follow: no public data

Portfolio highlights

  • Epigenica — Epigenica focuses on advancing epigenomics through its EpiFinder™ platform, a multiplexed ChIP-seq technology for high-throughput analysis of epigenetic marks. The company offers R&D services for the development of therapeutic molecules and diagnostic methods using epigenetics. Epigenica aims to improve scientists' ability to capture andextract insights from the epigenome, contributing to precision medicine and the discovery of new biomarkers.
  • Meru Health — Meru Health is an online mental health provider that helps people improve their mental health long-term by treating depression, anxiety, and burnout.
  • Health Integrator — Health Integrator is a digital marketplace for access to health services. The Health Integrator health platform provides easy access to a large number of activities and health services gathered in one place.
Show all investments...

Colibri Ventures
VC Fund · Solna, Stockholms Lan, Sweden · 1 investments in Sweden Biotechnology startups

Colibri Ventures invest in early-stage life science companies and help accelerate their innovations into commercial products.

Show more...

Investment focus

  • Industry: Gaming, Wellness, Health Care
  • Stage:Seed, Series A
  • Geography: Sweden, Mexico

Investor stats

  • Total investments: 3
  • Lead/follow: no public data

Portfolio highlights

  • Mundi — Mundi provides financial, trade development, strategy, freight and reinventing international trade services.
  • Mindforce Game Lab — Mindforce Game Lab creates meaningful games with characters that act as companions on the journey to better health.
  • Pixelgen Technologies — Understand the role of proteins in cellular organization with spatial proteomics. Get ahead in the field of proteomics with us.
Show all investments...

Almi Invest GreenTech
VC Fund · 1 investments in Sweden Biotechnology startups

Almi Invest GreenTech is a venture capital company and an active start-up investor.

Show more...

Investment focus

  • Industry: Waste Management, Energy, Manufacturing
  • Stage:Seed, Series A
  • Geography: Sweden

Investor stats

  • Total investments: 12
  • Lead/follow: no public data

Portfolio highlights

  • Zparq — Zparq designs and manufactures marine electric propulsion products.
  • Modvion — Modvion is a Swedish/ American Engineering and Industrial Design company developing modular designs in renewable engineered wood product materials to simplify and improve construction logistics.Their current area of focus is in wind tower technology. Modvion´s patented module technology enables significantly decreased cost, efficienttransportation and streamlined installation of towers exceeding 120 m. Ultimately, this results in increased cost efficiency in the harvesting of wind resources.
  • EnginZyme — EnginZyme is a biotechnology company that specializes in biocatalysis. It creates products for easy and cost-efficient implementation of biocatalytic processes and helps the chemical industry transition to a sustainable way of operating.The company is driven by a mission to make biocatalysis the first choice for chemical process designersworldwide.
Show all investments...

Nxt2b
VC Fund · Uppsala, Uppsala Lan, Sweden · 1 investments in Sweden Biotechnology startups

Nxt2b is a venture capital company focused on investments in healthcare, pharmaceuticals companies, and medical devices.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Health Diagnostics
  • Stage:Series A
  • Geography: Sweden

Investor stats

  • Total investments: 1
  • Lead/follow: no public data

Portfolio highlights

  • Navinci Diagnostics — Navinci is a Swedish biotech company specializing in innovative in situ proximity ligation assay-based solutions for spatial proteomics.
Show all investments...

KTH Holding
VC Fund · Stockholm, Stockholms Lan, Sweden · 1 investments in Sweden Biotechnology startups

KTH Holding is a state-owned limited company managed by KTH's University Board. It invests in promising startup companies that are based on research or teaching at KTH, with the aim of supporting commercialization and making it easier for new science to benefit society.

Show more...

Investment focus

  • Industry: Software, Information Technology, Biotechnology
  • Stage:Seed, Pre-Seed
  • Geography: Sweden

Investor stats

  • Total investments: 21
  • Lead/follow: no public data

Portfolio highlights

  • Cellfion — Cellfion provides sustainable materials for next level clean energy storage and conversion devices.​
  • porkchop — In-space logistics for SmallSats in Low Earth Orbit and beyond.
  • Novatron — A new fusion reactor design for stable plasma confinement and fusion power generation.
Show all investments...

Nordic Foodtech VC
VC Fund · Helsinki, Southern Finland, Finland · 1 investments in Sweden Biotechnology startups

We are investing in #FutureFood. Nordic FoodTech VC is the first fund in the Nordics investing explicitly in the future of food

Show more...

Investment focus

  • Industry: Biotechnology, Life Science, Water
  • Stage:Seed, Series A
  • Geography: Finland, Sweden, Denmark

Investor stats

  • Total investments: 26
  • Lead/follow: no public data

Portfolio highlights

  • EvodiaBio — Mirroring nature with pioneering bioscience for natural flavors
  • Endless Food — Endless Food Co is a food innovation firm focusing on the junction of pleasure and sustainability. Endless Food Co was pulled together by a common idea that the transition to a greener and more egalitarian future food system will be driven by flavor, and having spent the last decade pioneering sustainable gastronomy
  • Happy Plant Protein — Revolutionize plant protein production with Happy Plant Protein's innovative technology, transforming local ingredients into high-quality, sustainable solutions for the food industry.
Show all investments...

Knutsson Holdings AB
VC Fund · Gothenburg, Vastra Gotaland, Sweden · 1 investments in Sweden Biotechnology startups

Knutsson Holdings AB is an family owned private equity firm.

Show more...

Investment focus

  • Industry: Gaming, Billing, Parking
  • Stage:Series C
  • Geography: Sweden, Germany

Investor stats

  • Total investments: 4
  • Lead/follow: no public data

Portfolio highlights

  • Drifter — Drifter stays abreast of the latest technological trends in offering practical solutions for the parking and EV charging ecosystem.
  • Unicorn Workspaces — Unicorn offers work solutions for teams of all sizes with flexible terms and independent of high market rental prices. It is a fast-growing shared office provider, with 21 workspaces in Berlin, Potsdam, Cologne, Munich, Hamburg, and LisbonTheir vision of “Workspace as a Service” is reflected in their all-inclusive offer, and support fromcommunity baristas. They combine their coffee expertise and community manager knowledge to provide seamless work experience. With their friendly attitude and eagerness to help, members and visitors will receive good advice and assistance.Each of their workspaces is equipped with a modern café, where they offer organic direct trade coffee and hot beverages for all of their members and guests. They also offer a small selection of cold drinks, salads, and desserts. The café functions as a central meeting point for their community.
  • Resolution Games — Resolution Games is a Stockholm based studio focused on creating virtual reality (VR) and augmented reality (AR) immersive experiences for all.
Show all investments...

Kale United
VC Fund · Stockholm, Stockholms Lan, Sweden · 1 investments in Sweden Biotechnology startups

Kale United offers a portfolio of over 75+ plant-based game changers

Show more...

Investment focus

  • Industry: Food and Beverage, Biotechnology, Food Processing
  • Stage:Seed, Pre-Seed
  • Geography: Sweden, United Kingdom, Canada

Investor stats

  • Total investments: 24
  • Round size: Seed $360k–$2.5M; Pre-Seed $100k–$2M
  • Lead/follow: 4% lead, 96% follow

Portfolio highlights

  • Opalia — Opalia is introducing a new era of dairy: functional, delicious, and sustainable dairy made from mammary cells.
  • Hooked Foods — Leading the transition to a harmless seafood system by serving healthy vegan seafood for everybody to truly enjoy.
  • Cultimate Foods — At Cultimate, we are transforming the flavor and aroma industry with natural innovative ingredients.
Show all investments...

Biotechnology VC funding in Sweden at a glance

Stats across 319 deals from 285 investors.

285
investors
in Sweden Biotechnology startups
319
deals
in Sweden Biotechnology startups
$2.6M
median round
in Sweden Biotechnology startups
41%
lead investors
lead at least one round
15%
Grant
most common funding stage

Access all 285 VC funds in Sweden Biotechnology startups.

Open List

FAQ

Is Shizune data fresh/accurate?

Shizune has monitored hundreds of funding sources since 2020.

Our investor database is updated every day, so investor data is always fresh.

All metrics are calculated from confirmed public rounds, so the data is accurate.

Can I download investor list?

To download the Biotechnology VC Funds in Sweden investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.

You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.

Can I access investor database?

To access all 285 VC funds investing in Sweden Biotechnology startups and 48,091+ more investors, create a Shizune account.

Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.

The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.

You can enrich with email and download the data.

Does Shizune have investor emails and contacts?

Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.

To guarantee the highest discovery rate, we search across 20+ contact search tools.

To maximize delivery rate and reduce bounce rate, we validate emails.

You can enrich your investor list with Shizune. Download it too.

What is Shizune?

Shizune is a 48,091 investor database updated daily.

With Shizune you can:

  • browse the database
  • use smart matching
  • enrich with emails
  • download

All you need to find investors for your startup.

Who is Shizune for?

Shizune is built for startup founders by startup founders.

If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.

Is Shizune free?

Shizune is free forever. You can search and browse investors for free.

Email search and export are paid features.

For full info, visit our pricing.

Who built Shizune?

Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.

Contact 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!

More investor lists

Broader lists